Perspective Therapeutics, Inc. (AMEX:CATX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Heidi Henson Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 15, 2022); PepGen Inc. (Non-Executive Director · Since at least May 5, 2022); Pardes Biosciences Inc (Chief Financial Officer · Dec 23, 2021 – Aug 31, 2023 · Past); Kura Oncology, Inc. (Chief Financial Officer · Mar 6, 2015 – Jan 24, 2018 · Past) | Director · Since at least Jun 1, 2023 |
| Johan M Spoor Other companies: GridAI Technologies Corp. (Director · Oct 11, 2016 – Apr 6, 2020 · Past); MetaStat Inc (Director · May 22, 2012 – Dec 31, 2014 · Past); FluoroPharma Medical Inc (CEO, PRESIDENT, CHAIRMAN, Director · Nov 18, 2011 – Jan 7, 2014 · Past) | Chief Executive Officer, Director · Since at least Feb 3, 2023 |
| Frank Morich Other companies: Cue Biopharma, Inc. (Director · Since at least Jul 31, 2018) | Director · Since at least Feb 3, 2023 |
| Joel Sendek Other companies: Spero Therapeutics, Inc. (Chief Financial Officer · Nov 1, 2017 – Jan 2, 2019 · Past) | Chief Financial Officer · Since at least Sep 4, 2025 |
| Juan Graham Other companies: Kyntra Bio, Inc. (CHIEF FINANCIAL OFFICER · Sep 7, 2021 – Dec 6, 2024 · Past) | Chief Financial Officer · Jan 6, 2025 – Mar 28, 2025 · Past |
| Alan Hoffmann | Director · Jan 13, 2016 – Jul 21, 2022 · Past |
| Amos Hedt | Chief Business Strategy Officer · Since at least Nov 4, 2026 |
| Annie J. Cheng | Vice President, Investor Relations · Since at least Oct 23, 2026 |
| Belén Carrillo-Rivas | Senior Vice President, Global Regulatory Affairs · Since at least Nov 5, 2026 |
| Bernhard Sixt | Managing Director, Europe · Since at least Nov 5, 2026 |
| Brien Ragle | CFO · Oct 2, 2009 – Jun 21, 2016 · Past |
| Chris Nenno | General Counsel and Corporate Secretary · Since at least Nov 4, 2026 |
| Dwight William Babcock | CEO, Director · Mar 31, 2006 – Nov 12, 2015 · Past |
| Edwin Sagastume | Vice President, CMC Isotope Manufacturing · Since at least Nov 5, 2026 |
| Frank Morich | Member of the Board of Directors · Since at least Nov 4, 2026 |
| Fran Newark | Vice President, Clinical Operations · Since at least Nov 5, 2026 |
| Harry Jeffreys | Vice President, Quality · Since at least Nov 5, 2026 |
| Jeff Zhou | Vice President, Intellectual Property and Innovation · Since at least Nov 4, 2026 |
| John J. Grant | Senior Vice President, Business Development · Since at least Nov 5, 2026 |
| John Kappelhof | Senior Vice President, Program & Portfolio Management · Since at least Nov 5, 2026 |
| Jonathan Hunt | Chief Accounting Officer · Since at least Nov 13, 2025 |
| Krista Cline | Dir. of Operations, Secretary · Sep 11, 2018 – Jun 23, 2020 · Past |
| Lori Woods | Chairperson · Since at least Dec 12, 2023 |
| Maria E Martinez | Director · Since at least Sep 3, 2025 |
| Markus Puhlmann | Chief Medical Officer · Since at least Dec 12, 2023 |
| Matthew Branson | Principal Fin & Acct Officer · Jan 17, 2017 – Jun 15, 2017 · Past |
| Maya Martinez-Davis | Member of the Board of Directors · Since at least Sep 3, 2025 |
| Mengshi Li | Vice President, Pipeline Discovery · Since at least Nov 5, 2026 |
| Michael Krachon | EVP of Sales & Marketing · Jun 14, 2016 – Oct 22, 2020 · Past |
| Michael W McCormick | Director · Jun 18, 2019 – Feb 21, 2023 · Past |
| Paul Lyne | Chief Science Officer · Since at least Nov 5, 2026 |
| Philip J Vitale | Director · Jan 15, 2014 – Jul 21, 2022 · Past |
| Robert Froman Williamson | Member of the Board of Directors · Since at least Nov 5, 2026 |
| Robert F Williamson III | Director · Since at least Feb 3, 2023 |
| Roger Girard | CEO & President, Director · Aug 8, 2006 – Nov 12, 2007 · Past |
| Sarah Wille | Vice President, People & Culture · Since at least Nov 5, 2026 |
| Shane Cobb | Executive Vice President, Operations · Since at least Nov 5, 2026 |
| Shilpen Patel | Senior Vice President, Clinical Development · Since at least Nov 5, 2026 |
| Thijs Spoor | Chief Executive Officer & Member of the Board of Directors · Since at least Oct 23, 2026 |
| William Cavanagh | Chief R&D Officer · Oct 7, 2010 – Jul 21, 2022 · Past |